Classification Nuance. The OpenFDA dataset, which draws from the Structured Product Labeling (SPL) files, often includes multiple classification fields, and the specific string "Phosphate Binder [EPC]" may only be assigned to a single product. The other drugs are likely classified using: More Specific Classes: Many of those drugs (like sevelamer, ferric citrate, etc.) may be classified by their specific mechanism or chemical group, which also acts as a phosphate binder. Example: A drug might be classified as "Iron-Containing Compound [EPC]" or "Aluminum-Containing Compound [EPC]" instead of the more general "Phosphate Binder [EPC]". Different Classification Fields: The NDC data contains several classification fields. You might be checking the Established Pharmacological Class (pharm_class_epc), but the other drugs might be listed under: Mechanism of Action (pharm_class_moa), Physiological Effect (pharm_class_pe)
  Home  

Enter a class name or drug name above to search the database.

Phosphodiesterase 4 Inhibitor [EPC]

NDC Number Brand Name Generic Name Manufacturer Dosage Form DEA Sch. Marketing Start Date
0310-0088 Daliresp roflumilast AstraZeneca Pharmaceuticals LP TABLET 2015-07-01
0310-0095 Daliresp roflumilast AstraZeneca Pharmaceuticals LP TABLET 2015-07-01
0378-1905 Roflumilast Roflumilast Mylan Pharmaceuticals Inc. TABLET 2022-10-19
0904-7399 Roflumilast Roflumilast MAJOR PHARMACEUTICALS TABLET 2022-09-07
0904-7483 Roflumilast Roflumilast Major Pharmaceuticals TABLET 2024-05-22
31722-623 Roflumilast Roflumilast Camber Pharmaceuticals, Inc. TABLET 2022-10-15
31722-676 Roflumilast Roflumilast Camber Pharmaceuticals, Inc. TABLET 2023-04-18
42571-259 ROFLUMILAST Roflumilast Micro Labs Limited TABLET 2022-10-19
42571-369 ROFLUMILAST ROFLUMILAST Micro Labs Limited TABLET 2023-05-01
43547-005 ROFLUMILAST roflumilast Solco Healthcare US, LLC. TABLET 2022-05-10
51407-975 Roflumilast Roflumilast Golden State Medical Supply, Inc. TABLET 2023-04-18
55513-137 Otezla apremilast Amgen, Inc TABLET, FILM COATED 2020-02-26
55513-369 Otezla apremilast Amgen, Inc KIT 2020-02-26
55513-485 Otezla apremilast Amgen, Inc KIT 2020-02-26
55513-497 Otezla apremilast Amgen, Inc TABLET, FILM COATED 2024-04-25
55513-508 Otezla apremilast Amgen, Inc KIT 2024-04-25
55513-516 Otezla apremilast Amgen, Inc KIT 2020-02-26
55513-519 Otezla apremilast Amgen, Inc TABLET, FILM COATED 2025-08-31
55513-996 Otezla apremilast Amgen, Inc KIT 2024-04-25
55724-211 Eucrisa crisaborole Pfizer Laboratories Div Pfizer Inc OINTMENT 2017-01-30
59651-275 ROFLUMILAST ROFLUMILAST Aurobindo Pharma Limited TABLET 2023-04-17
59651-801 ROFLUMILAST ROFLUMILAST Aurobindo Pharma Limited TABLET 2025-01-31
60219-1410 APREMILAST APREMILAST Amneal Pharmaceuticals NY LLC TABLET, FILM COATED 2021-07-05
60219-1744 APREMILAST APREMILAST Amneal Pharmaceuticals NY LLC KIT 2021-07-05
60687-786 Roflumilast Roflumilast American Health Packaging TABLET 2023-12-07
64380-786 roflumilast ROFLUMILAST Strides Pharma Science Limited TABLET 2022-10-13
67877-480 Roflumilast Roflumilast Ascend Laboratories, LLC TABLET 2025-03-14
67877-730 Roflumilast Roflumilast Ascend Laboratories, LLC TABLET 2025-03-14
68382-624 Roflumilast Roflumilast Zydus Pharmaceuticals USA Inc. TABLET 2023-05-18
68382-969 Roflumilast Roflumilast Zydus Pharmaceuticals USA Inc. TABLET 2022-10-03
70771-1673 Roflumilast Roflumilast Zydus Lifesciences Limited TABLET 2023-05-18
70771-1674 Roflumilast Roflumilast Zydus Lifesciences Limited TABLET 2022-10-03
72162-2385 ROFLUMILAST Roflumilast Bryant Ranch Prepack TABLET 2022-10-19
72205-200 Roflumilast Roflumilast Novadoz Pharmaceuticals LLC TABLET 2022-09-07
72205-201 Roflumilast Roflumilast Novadoz Pharmaceuticals LLC TABLET 2022-09-07
80610-105 ZORYVE roflumilast Arcutis Biotherapeutics, Inc. CREAM 2025-10-04
80610-115 ZORYVE roflumilast Arcutis Biotherapeutics, Inc. CREAM 2024-07-09
80610-130 ZORYVE roflumilast Arcutis Biotherapeutics, Inc. CREAM 2022-07-29
80610-430 ZORYVE roflumilast Arcutis Biotherapeutics, Inc. AEROSOL, FOAM 2023-12-15
83034-003 Ohtuvayre ensifentrine Verona Pharma, Inc. SUSPENSION 2024-06-26



 [EPC] Established Pharmacological Classification 

Loading full table content...